LUPS-Lipids and Glucose Under Prospective Surveillance

Lipids and Glucose Under Prospective Surveillance

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01313156

Acronym

LUPS

Enrollment

1962

Registered

2011-03-11

Start date

2008-11-30

Completion date

2019-08-31

Last updated

2019-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome, Type 2 Diabetes

Keywords

Metabolic Syndrome, Syndrome X, MetS,, Type 2 Diabetes

Brief summary

Prospective, non-randomized cohort study to analyse genetic variations, dietary patterns, perceived stress and anxiety and early changes in lipid metabolism leading to the metabolic syndrome and type 2 diabetes

Detailed description

The LUPS-study is a collaboration between Asklepios Clinics Hamburg GmbH and University Clinic Hamburg Eppendorf, Germany. This study is assessing a multitude of serum biomarkers, anthropometrics, dietary habits, physical activity, perceived stress along with genetic information from healthy workers (25-60years) to better understand phenotype-genotype associations leading to MetS and type 2 diabetes.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

25 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* 25-60 years men and women willing to give consent

Exclusion criteria

* diabetes (type 1 or 2)

Design outcomes

Primary

Measure	Time frame	Description
Metabolic Syndrome, Type 2 Diabetes	10 years	assessing risk factors, e.g. HDL, BMI, Blood Pressure, FPG

Countries

Germany

Outcome results